CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
106-120 of 1187
Setting the Stage: Understanding Rett Through Patient Perspectives
Neurology and NeurosurgerySetting the Stage: Understanding Rett Through Patient Perspectives
Chairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
CME/CEChairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
- CME/CE In-Person & Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026
Houston, Texas Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CEPrecision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®Comparing Trial Designs & Outcomes Across IGF-1R Therapies
- advertisement
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Designing Efficient Clinic Workflows for TED Therapy Access
MinuteCE®Designing Efficient Clinic Workflows for TED Therapy Access
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®Why Staging TED Correctly Matters Even When CAS Is Low
Overcoming Real-World Barriers to TED Treatment
MinuteCE®Overcoming Real-World Barriers to TED Treatment
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
MinuteCE®Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
- advertisement
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
CME/CEThe Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies

















































